Kim Sablich
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Kim Sablich
The proxy statement of Jazz Pharmaceuticals plc reports total compensation of $4,165,304 for Kim Sablich in fiscal 2023, including a base salary of $632,412. Disclosed compensation is on record for 4 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Jazz Pharmaceuticals plc (JAZZ)
Proxy statement
Start not stated–2023-06-16
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Jazz Pharmaceuticals plc (JAZZ) | Former Executive Vice President and General Manager, US | $632,412 | $4,165,304 |
| 2022 | Jazz Pharmaceuticals plc (JAZZ) | Former Executive Vice President and General Manager, US | $606,146 | $4,303,200 |
| 2021 | Jazz Pharmaceuticals plc (JAZZ) | Former Executive Vice President and General Manager, US | $566,923 | $3,947,509 |
| 2020 | Jazz Pharmaceuticals plc (JAZZ) | Executive Vice President and General Manager, US | $327,885 | $4,621,245 |
Recent activity
No call appearances or filed executive changes recorded yet.